Related content

Does long-term treatment with Doxil ® predispose patients to oral cancer?

By Ben-David Yehuda  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 554-555

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study

By            

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 935-939

Spandidos Publications

Access to resources Recommend Favorite

Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications

By Masci Giovanna   Magagnoli Massimo   Pedicini Vittorio   Poretti Dario   Castagna Luca   Carnaghi Carlo   Morenghi Emanuela   Vecchio Antonietta   Finotto Rita   Brambilla Giorgio   Santoro Armando  

Supportive Care in Cancer, Vol. 14, Iss. 11, 2006-11 ,pp. : 1141-1146

Springer Publishing Company

Access to resources Recommend Favorite

Gastrointestinal Cancer and the Long-term Use of Pravastatin in the Elderly

By Devroey Dirk   Buntinx Frank   Betz Willem   Vandevoorde Jan   Kartounian Jan  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 347-348

Informa Healthcare

Access to resources Recommend Favorite

Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 619-623

Spandidos Publications

Access to resources Recommend Favorite